Subscribe
migraine-head
ESB Professional / shutterstock.com
9 July 2020EuropeMuireann Bolger

Teva loses TM appeal over ‘French version’ of slogan

Drug company  Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the  EU General Court ruled in favour of the  European Union IP Office (EUIPO) yesterday, July 8.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
EIP hires Teva litigator
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
European Commission calls out Teva over anti-competitive practice
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
Teva withdraws Shield patent oppositions
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
EIP hires Teva litigator
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
European Commission calls out Teva over anti-competitive practice
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
Teva withdraws Shield patent oppositions
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

More on this story

Big Pharma
EIP hires Teva litigator
7 January 2014   EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Big Pharma
European Commission calls out Teva over anti-competitive practice
18 July 2017   The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.
Big Pharma
Teva withdraws Shield patent oppositions
19 October 2020   Israeli generics company Teva has withdrawn its oppositions to two patents owned by Shield Therapeutics before the European Patent Office.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent